Skip to main content
. 2012 Sep 10;20(1):28. doi: 10.1186/2008-2231-20-28

Table 2.

Comparison of resistance pattern of isolated bacteria of nosocomial origin in four-year period

Antimicrobial agent/ microorganism Susceptibility
Sensitive; n (%)
Intermediate; n (%)
Resistant; n (%)
2007 2008 2009 2010 2007 2008 2009 2010 2007 2008 2009 2010
Amikacin
Acinetobacter
8
13
7
1
1
0
0
1
9
6
9
8
Citrobacter
4
5
11
N/A
1
0
0
N/
7
7
20
N/
E.Coli
62
85
53
26
2
0
0
A
10
8
16
A
Enterobacter
20
34
25
13
0
0
1
0
1
1
3
4
Kelebsiella
13
10
12
4
2
0
0
0
7
1
6
1
Proteus spp.
8
4
13
5
0
0
0
1
3
0
1
1
Pseudomonas sp.
9
18
12
11
0
0
0
0
2
3
11
6
Stenotrophomonas sp.
9
40
83
25
2
1
0
0
11
31
29
24
Total
133 (69.6%)
209 (78.3%)
216 (69.2%)
85 (64.4%)
8 (4.2%)
1 (0.3%)
1 (0.3%)
1 3 (2.3%)
50 (26.2%)
57 (21.3%)
95 (30.4%)
44 (33.3%)
Ampicillin/sulbactam
Acinetobacter
1
5
11
3
0
0
0
0
3
3
10
5
E.Coli
3
6
15
7
0
0
2
1
2
12
49
15
Enterobacter
5
3
9
4
0
0
1
0
0
5
15
1
Kelebsiella
0
1
5
1
0
0
0
0
3
1
11
4
Proteus spp.
1
2
11
5
0
0
0
0
0
0
4
0
Pseudomonas sp.
0
0
3
0
0
0
0
0
2
4
20
14
Stenotrophomonas sp.
1
1
1
1
1
0
0
1
9
19
5
2
Total
11 (35.5%)
18 (29%)
55 (32%)
21 (32.8%)
1 (3.2%)
0 (0)
3 (1.7%)
2 (3.1%)
19 (61.3%)
44 (71%)
114 (66.3%)
41 (64.1%)
Ampicillin
E.Coli
0
0
1
1
0
0
0
0
2
22
25
0
Enterobacter
0
0
2
0
0
0
0
0
1
5
4
2
Total
0 (0)
0 (0)
3 (9.4%)
1 (33.3%)
0 (0)
0 (0)
0 (0)
0 (0)
3 (100%)
27 (100%)
29 (90.6%)
2 (66.7%)
Cotrimoxazole
Acinetobacter
7
6
5
1
0
0
0
0
14
10
13
8
Citrobacter
1
2
3
1
0
0
0
0
6
6
13
1
E.Coli
21
19
24
8
0
0
1
0
49
59
47
20
Enterobacter
12
24
21
8
0
0
0
0
11
13
7
4
Kelebsiella
6
5
7
2
0
0
0
0
17
3
12
4
Proteus spp.
4
2
4
3
0
1
0
0
7
3
9
1
Pseudomonas sp.
0
7
4
2
0
0
0
0
13
11
20
14
Stenotrophomonas sp.
22
78
107
35
0
0
0
0
1
2
2
10
Total
73 (38.2%)
143 (57%)
173 (58.2%)
60 (49.2%)
0 (0)
1 (0.4%)
1 (0.4%)
0 (0)
118 (61.8%)
107 (42.6%)
123 (41.4%)
62 (51.8%)
Cefepim
E.Coli
3
4
7
2
0
0
0
0
3
3
5
1
Enterobacter
0
4
5
1
0
0
0
0
1
6
2
1
Proteus spp.
1
0
4
1
0
1
0
0
1
2
0
0
Pseudomonas sp.
0
0
2
1
0
0
0
0
1
8
4
3
Total
4 (40%)
8 (28.6%)
18 (62.1%)
5 (50%)
0 (0)
1 (3.6%)
0 (0)
0 (0)
6 (60%)
19 (67.9%)
11 (37.9%)
5 (50%)
Cefixime
Acinetobacter
0
0
1
0
0
0
0
0
4
7
3
1
E.Coli
3
2
2
0
0
0
0
0
11
10
0
1
Enterobacter
3
6
1
0
1
2
0
1
3
11
2
4
Proteus spp.
1
0
4
1
0
1
0
0
1
2
0
0
Pseudomonas sp.
0
0
2
1
0
0
0
0
1
8
4
3
Total
7 (25%)
8 (40%)
10 (52.6%)
2 (16.7%)
1 (3.6%)
3 (15%)
0 (0)
1 (8.3%)
20 (71.4%)
9 (45%)
9 (47.4%)
9 (75%)
Cefotaxim
Acinetobacter
1
1
0
1
0
0
0
0
4
3
5
1
Citrobacter
0
1
0
1
0
0
0
0
5
1
2
1
Pseudomonas sp.
0
1
0
1
0
0
0
0
4
1
4
1
Stenotrophomonas sp.
1
0
0
0
2
0
0
0
5
8
3
1
Total
2 (10%)
3 (18.7%)
0 (0)
3 (42.8%)
0 (0)
0 (0)
0 (0)
0 (0)
18 (90%)
13 (91.3%)
14 (100%)
4 (57.2%)
Ceftazidim
Acinetobacter
0
0
2
2
0
0
0
0
4
8
5
2
E.Coli
3
3
7
15
0
0
1
0
4
16
43
6
Enterobacter
5
1
12
7
0
0
1
0
0
9
8
4
Kelebsiella
2
1
6
0
0
1
0
0
0
4
7
2
Proteus spp.
2
0
8
4
0
1
0
0
2
3
1
0
Pseudomonas sp.
2
0
4
3
0
0
0
0
1
12
12
4
Stenotrophomonas sp.
0
5
1
2
0
1
0
0
9
31
1
6
Total
14 (41.2%)
10 (10.4%)
40 (33.6%)
33 (57.9%)
0 (0)
3 (3.1%)
2 (1.7%)
0 (0)
20 (58.8%)
83 (86.4%)
77 (64.7%)
24 (42.1%)
Ciprofloxacin
Acinetobacter
9
4
7
1
0
1
0
0
8
8
13
6
E.Coli
19
26
24
13
0
0
0
0
44
51
49
18
Enterobacter
12
18
24
8
0
0
0
0
8
7
8
2
Kelebsiella
6
4
10
4
2
0
0
0
20
7
20
7
Proteus spp.
4
2
8
6
0
0
0
0
5
3
7
0
Pseudomonas sp.
8
6
10
12
0
1
1
0
2
9
14
3
Stenotrophomonas sp.
15
39
109
45
0
0
0
0
3
0
0
1
Total
73 (44.2%)
99 (53.2%)
192 (63.2%)
80 (68.4%)
2 (1.2%)
2 (1.1%)
1 (0.3%)
0 (0)
90 (54.5%)
85 (45.7%)
111 (36.5%)
37 (31.6%)
Gentamicin
Acinetobacter
5
9
4
1
1
0
0
0
9
2
6
5
E.Coli
18
49
24
12
1
1
2
0
32
35
36
8
Enterobacter
9
23
21
5
0
0
1
0
4
6
5
1
Kelebsiella
7
4
10
3
0
0
0
0
11
5
5
3
Proteus spp.
2
5
8
1
1
0
0
0
4
0
0
1
Pseudomonas sp.
5
12
1
4
0
0
0
0
3
7
10
2
Stenotrophomonas sp.
8
31
3
2
1
2
0
0
4
9
3
0
Total
54 (43%)
133 (66.5%)
71 (51.1%)
28 (58.3%)
4 (3%)
3 (1.5%)
3 (2.2%)
0 (0%)
67 (54%)
64 (32%)
65 (46.8%)
20 (51.7%)
Imipenem
Acinetobacter
8
15
20
7
0
3
0
1
4
0
1
3
E.Coli
25
47
77
29
0
0
0
0
0
0
0
2
Enterobacter
12
30
31
13
0
0
0
0
0
0
0
1
Kelebsiella
10
8
19
8
0
0
0
0
0
0
0
0
Proteus spp.
7
6
17
6
0
0
0
0
0
0
0
0
Pseudomonas sp.
9
22
26
15
0
0
0
0
1
0
1
1
Stenotrophomona s sp.
2
10
2
2
0
1
1
0
20
49
7
9
Total
73 (74.5%)
132 (71.3%)
192 (95%)
80 (82.5%)
0 (0)
4 (2.2%)
1 (0.5%)
1 (1%)
25 (25.5%)
49 (26.5%)
9 (4.5%)
16 (16.5%)
Nitrofurantoin
Acinetobacter
2
2
1
0
0
0
0
0
5
3
0
2
E.Coli
31
68
39
10
1
1
0
0
2
11
11
1
Enterobacter
4
8
8
1
1
1
0
0
1
8
3
0
Kelebsiella
5
2
5
3
0
0
1
0
1
3
3
2
Proteus spp.
1
1
0
0
0
0
0
0
2
0
1
1
Pseudomonas sp.
1
0
0
0
0
0
1
0
1
8
3
5
Total
44 (75.9%)
81 (69.8%)
53 (69.7%)
14 (56%)
2 (3.5%)
2 (1.7%)
2 (2.6%)
0 (0)
12 (20.7%)
33 (28.5%)
21 (27.6%)
11 (44%)
Piperacillin
Acinetobacter
2
4
N/A
0
1
0
N/A
0
5
3
N/A
3
E.Coli
2
0
N/A
1
0
0
N/A
0
18
4
N/A
0
Enterobacter
9
14
N/A
6
0
0
N/A
0
2
4
N/A
1
Kelebsiella
3
2
N/A
1
0
0
N/A
0
6
4
N/A
0
Total
16 (33.3%)
20 (57.1%)
N/A
8 (66.7%)
1 (2.1%)
0 (0)
N/A
0 (0)
31 (64.6%)
15 (42.9%)
N/A
4 (33.3%)
Ceftriaxone
Acinetobacter
1
6
4
0
0
0
0
0
15
13
10
9
E.Coli
17
40
16
13
0
1
1
0
51
50
55
17
Enterobacter
9
19
19
10
0
0
1
0
9
12
8
5
Kelebsiella
3
3
5
2
1
0
0
0
16
6
13
4
Proteus spp.
5
3
14
6
0
0
0
0
5
0
2
0
Pseudomonas sp.
2
2
4
5
0
4
1
0
7
13
19
8
Stenotrophomonas sp.
1
5
3
2
0
0
1
0
16
65
91
49
Total
39 (24.5%)
78 (32.2%)
65 (24.3%)
38 (29.2%)
1 (0.6%)
5 (2.1%)
4 (1.5%)
0 (0)
119 (74.8%)
159 (65.7%)
198 (74.2%)
92 (70.8%)
Piperacillin/tazobactam
Acinetobacter
2
1
12
3
0
0
0
0
1
1
5
0
E.Coli
1
3
22
18
0
0
0
0
0
1
0
0
Proteus spp.
1
1
12
5
0
0
0
0
0
0
0
3
Pseudomonas sp.
1
3
13
6
0
0
0
1
1
0
4
0
Stenotrophomonas sp.
2
3
5
2
0
0
0
0
0
1
1
0
Total 7 (77.8%) 11 (78.6%) 64 (86.5%) 34 (89.5%) 0 (0) 0 (0) 0 (0) 1 (2.6%) 2 (22.2%) 3 (21.4%) 10 (13.5%) 3 (7.9%)